Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases

Background: Spinal metastasis pain includes both inflammatory and neuropathic pain, and opioids, which have only a ?-opioid receptor-stimulating effect, are generally less effective in neuropathic pain. However, no previous study has been conducted for the comparisons of the efficacy of opioids in t...

Full description

Bibliographic Details
Main Authors: Miho Takemura, Kazuyuki Niki, Yoshiaki Okamoto, Hiroshi Tamura, Tomohiro Kawamura, Makie Kohno, Yoshinobu Matsuda, Kenji Ikeda
Format: Article
Language:English
Published: Mary Ann Liebert 2023-08-01
Series:Palliative Medicine Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/full/10.1089/PMR.2023.0018
_version_ 1797346089696755712
author Miho Takemura
Kazuyuki Niki
Yoshiaki Okamoto
Hiroshi Tamura
Tomohiro Kawamura
Makie Kohno
Yoshinobu Matsuda
Kenji Ikeda
author_facet Miho Takemura
Kazuyuki Niki
Yoshiaki Okamoto
Hiroshi Tamura
Tomohiro Kawamura
Makie Kohno
Yoshinobu Matsuda
Kenji Ikeda
author_sort Miho Takemura
collection DOAJ
description Background: Spinal metastasis pain includes both inflammatory and neuropathic pain, and opioids, which have only a ?-opioid receptor-stimulating effect, are generally less effective in neuropathic pain. However, no previous study has been conducted for the comparisons of the efficacy of opioids in treating spinal metastasis pain. Objective: To compare the efficacy of tapentadol and methadone with other opioids for back pain caused by a metastatic spinal tumor. Design: Retrospective cohort study. Setting/Subjects: A total of 274 patients were enrolled, who started a tapentadol extended-release tablet, methadone tablet, hydromorphone extended-release tablet, oxycodone extended-release tablet, or transdermal fentanyl patch for cancer pain due to spinal metastasis in Japan from January 1, 2013 to October 31, 2021. Measurements: The primary endpoint, the difference in the numerical rating scale (NRS) scores before and seven days after each opioid administration, was compared among the five groups. Results: In patients with numbness, a decrease of the NRS score on day seven compared with before starting each opioid was significantly higher in the tapentadol group than those in the hydromorphone, oxycodone, and fentanyl groups and comparable to that in the methadone group. In patients without numbness, no significant differences were observed in decreases of the NRS scores on day seven among the five groups. Conclusions: Tapentadol and methadone may be more effective than hydromorphone, oxycodone, and fentanyl for cancer pain due to spinal metastasis with numbness.
first_indexed 2024-03-08T11:26:47Z
format Article
id doaj.art-62266510d97c40f28e1eaacea8b81fbd
institution Directory Open Access Journal
issn 2689-2820
language English
last_indexed 2024-03-08T11:26:47Z
publishDate 2023-08-01
publisher Mary Ann Liebert
record_format Article
series Palliative Medicine Reports
spelling doaj.art-62266510d97c40f28e1eaacea8b81fbd2024-01-26T05:09:40ZengMary Ann LiebertPalliative Medicine Reports2689-28202023-08-014122023010.1089/PMR.2023.0018Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal MetastasesMiho TakemuraKazuyuki NikiYoshiaki OkamotoHiroshi TamuraTomohiro KawamuraMakie KohnoYoshinobu MatsudaKenji IkedaBackground: Spinal metastasis pain includes both inflammatory and neuropathic pain, and opioids, which have only a ?-opioid receptor-stimulating effect, are generally less effective in neuropathic pain. However, no previous study has been conducted for the comparisons of the efficacy of opioids in treating spinal metastasis pain. Objective: To compare the efficacy of tapentadol and methadone with other opioids for back pain caused by a metastatic spinal tumor. Design: Retrospective cohort study. Setting/Subjects: A total of 274 patients were enrolled, who started a tapentadol extended-release tablet, methadone tablet, hydromorphone extended-release tablet, oxycodone extended-release tablet, or transdermal fentanyl patch for cancer pain due to spinal metastasis in Japan from January 1, 2013 to October 31, 2021. Measurements: The primary endpoint, the difference in the numerical rating scale (NRS) scores before and seven days after each opioid administration, was compared among the five groups. Results: In patients with numbness, a decrease of the NRS score on day seven compared with before starting each opioid was significantly higher in the tapentadol group than those in the hydromorphone, oxycodone, and fentanyl groups and comparable to that in the methadone group. In patients without numbness, no significant differences were observed in decreases of the NRS scores on day seven among the five groups. Conclusions: Tapentadol and methadone may be more effective than hydromorphone, oxycodone, and fentanyl for cancer pain due to spinal metastasis with numbness.https://www.liebertpub.com/doi/full/10.1089/PMR.2023.0018bone metastasis paincancer pain managementmethadoneopioidsspinal metastasistapentadol
spellingShingle Miho Takemura
Kazuyuki Niki
Yoshiaki Okamoto
Hiroshi Tamura
Tomohiro Kawamura
Makie Kohno
Yoshinobu Matsuda
Kenji Ikeda
Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases
Palliative Medicine Reports
bone metastasis pain
cancer pain management
methadone
opioids
spinal metastasis
tapentadol
title Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases
title_full Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases
title_fullStr Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases
title_full_unstemmed Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases
title_short Differences in the Analgesic Effect of Opioids on Pain in Cancer Patients With Spinal Metastases
title_sort differences in the analgesic effect of opioids on pain in cancer patients with spinal metastases
topic bone metastasis pain
cancer pain management
methadone
opioids
spinal metastasis
tapentadol
url https://www.liebertpub.com/doi/full/10.1089/PMR.2023.0018
work_keys_str_mv AT mihotakemura differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT kazuyukiniki differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT yoshiakiokamoto differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT hiroshitamura differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT tomohirokawamura differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT makiekohno differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT yoshinobumatsuda differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases
AT kenjiikeda differencesintheanalgesiceffectofopioidsonpainincancerpatientswithspinalmetastases